ARCHIVES

FDA Committee Okays High Dose Methotrexate, Mitxantrone In ANL; reverse Breast Cancer Vote

This article is from The Cancer Letter archive.

Vol. 13 No. 48 | December 11, 1987

Download PDF Visit The Full Archive

Related Articles

In Brief: All 77 New NCI Positions Go to Carcinogenesis Programs; “Not Wisest Way To Use Them” – Newell

February 4, 1977

DCIS With Higher Density May Increase Risk For Disease

October 29, 2010

Bishop Completes Term As NCAB Chairman; Terms Of Five Extended Awaiting W.H. Action.

February 25, 2000

Longer Infusion More Effective For Pancreatic Cancer

September 26, 2003

NCI Cooperative Group, Cancer Center Trials Listed

October 28, 2005

Who Will Determine Pay Lines For Each Program at NCI? Upton Suggests A Collective Approach

February 17, 1978